Status:
COMPLETED
Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease
Lead Sponsor:
Pfizer
Conditions:
Alzheimer Disease
Caregivers
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
A unique multinational study was conducted simultaneously in the USA, England and Australia. The goals of the study were to answer two questions: Does psychosocial support for the family enhance the e...
Detailed Description
This study is a single-blind prospective randomized trial with 150 patient/caregiver pairs (50 in each country). Eligibility criteria at baseline require that the primary caregiver is the spouse of th...
Eligibility Criteria
Inclusion
- Individuals diagnosed with mild to moderate stage Alzheimer's disease and their spouse caregivers
Exclusion
- Severe psychological or physical illness
- Unwillingness by either spouse to participate in all aspects of the study
Key Trial Info
Start Date :
July 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2003
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00467766
Start Date
July 1 1999
End Date
June 1 2003
Last Update
May 7 2007
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Aging and Dementia Research Center, Silberstein Institute, NYU School of Medicine
New York, New York, United States, 10016
2
Prince of Wales Hospital
Randwick, New South Wales, Australia, 2031
3
University of Manchester, Division of Psychiatry
Manchester, United Kingdom, M23 9LT